News & Views

Read the latest from Baszucki Group and its partners.

Why Three Deep-Pocketed Funders Joined Forces to Take on Bipolar Disorder

October 3, 2022 — Three families who have been personally affected by bipolar disorder came together to bring new treatment options to families across the world. BD², Breakthrough Discoveries for thriving with Bipolar Disorder, will serve as a global platform to coordinate science across disciplines and national borders to tackle this complex and still poorly understood disorder.

Read More

Sergey Brin, Roblox’s David Baszucki and Kent Dauten Of Keystone Capital Commit $150 Million To Fight Bipolar Disorder

September 12, 2022 — Google cofounder Sergey Brin; Roblox founder David Baszucki and his wife, author Jan Ellison Baszucki; and Keystone Capital chairman Kent Dauten and his wife Liz Dauten launched a global endeavor called BD² Breakthrough Discoveries for thriving with Bipolar Disorder.

Read More

Global Platform Launches to Transform Bipolar Disorder Research and Care

September 12, 2022 — The Baszucki, Dauten, and Brin families joined with the Milken Institute to launch BD²: Breakthrough Discoveries for thriving with Bipolar Disorder. As the largest private investment focused on the study of bipolar disorder, BD² provides an unprecedented opportunity to identify breakthroughs in scientific understanding that create new interventions so that everyone with bipolar disorder can thrive.

Read More

Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression

September 6, 2022 — The FDA has approved the SAINT Neuromodulation System for the treatment of major depressive disorder in adults who have not seen improvement using antidepressant medications. The Baszuckis are proud to have partnered with Nolan Williams and Magnus Medical to make this timely and personalized treatment accessible to patients with debilitating conditions.

Read More